Press Release2018-05-11T01:29:54-04:00

VLP Therapeutics Japan, a wholly owned subsidiary of VLP Therapeutics, has been selected by the Japanese government AMED fund for development of a protective vaccine against the new coronavirus infectious disease (COVID-19)